We are live on ! Find out more
ERP

Eldred Rock Partners Portfolio holdings

AUM $465M
1-Year Est. Return 48.86%
This Fund
S&P 500
This Quarter Est. Return
+13.63%
1 Year Est. Return
+48.86%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$183M
AUM Growth
+$26.5M
Cap. Flow
+$5.48M
Cap. Flow %
2.99%
Top 10 Hldgs %
62.44%
Holding
27
New
2
Increased
22
Reduced
1
Closed
1
Avg Time Held
0.9 quarters
Top 10 Avg Time Held
1 quarter
Top 20 Avg Time Held
1 quarter

Top Buys

Rank Stock Value
1
IBOC icon
International Bancshares
IBOC
+$7.34M
2
UL icon
Unilever
UL
+$1.57M
3
BNS icon
Scotiabank
BNS
+$1.07M
4
ASML icon
ASML
ASML
+$155K
5
LRCX icon
Lam Research
LRCX
+$153K

Top Sells

Rank Stock Value
1
CHRW icon
C.H. Robinson
CHRW
+$6.21M
2
NVO
Novo Nordisk
NVO
+$319K

Sector Composition

Rank Sector Weight
1 Financials 26.3%
2 Technology 22.02%
3 Healthcare 11.83%
4 Industrials 10.05%
5 Consumer Staples 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LRCX icon
1
Lam Research
LRCX
$401B
$16.5M 8.99%
169,710
+1,740
+1% +$153K
2023 Q4
1 quarter
PSX icon
2
Phillips 66
PSX
$112B
$12.9M 7.02%
78,909
+781
+1% +$113K
2023 Q4
1 quarter
MRK icon
3
Merck
MRK
$351B
$12.5M 6.79%
94,487
+940
+1% +$116K
2023 Q4
1 quarter
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.26T
$12.1M 6.58%
80,024
+801
+1% +$115K
2023 Q4
1 quarter
KMX icon
5
CarMax
KMX
$7.64B
$11.2M 6.12%
128,889
+1,265
+1% +$95.7K
2023 Q4
1 quarter
BN icon
6
Brookfield
BN
$82.1B
$10.4M 5.67%
372,572
+3,642
+1% +$98.2K
2023 Q4
1 quarter
BRK.B icon
7
Berkshire Hathaway Class B
BRK.B
$1.09T
$10.4M 5.64%
24,629
+252
+1% +$99.1K
2023 Q4
1 quarter
DFS
8
DELISTED
Discover Financial Services
DFS
$9.65M 5.26%
73,636
+941
+1% +$108K
2023 Q4
1 quarter
ACN icon
9
Accenture
ACN
$128B
$9.51M 5.18%
27,448
+279
+1% +$102K
2023 Q4
1 quarter
EMR icon
10
Emerson Electric
EMR
$88.7B
$9.5M 5.18%
83,759
+827
+1% +$84.9K
2023 Q4
1 quarter
CMI icon
11
Cummins
CMI
$71.6B
$8.94M 4.87%
30,335
+303
+1% +$78.1K
2023 Q4
1 quarter
CALM icon
12
Cal-Maine
CALM
$3.03B
$7.86M 4.28%
133,531
+1,314
+1% +$74.8K
2023 Q4
1 quarter
IBOC icon
13
International Bancshares
IBOC
$4.25B
$7.77M 4.23%
+138,321
New +$7.34M
2024 Q1
0 quarters
TROW icon
14
T. Rowe Price
TROW
$22.2B
$7.74M 4.22%
63,480
+799
+1% +$89.2K
2023 Q4
1 quarter
TXN icon
15
Texas Instruments
TXN
$263B
$7.49M 4.08%
42,993
+431
+1% +$71.9K
2023 Q4
1 quarter
PEP icon
16
PepsiCo
PEP
$175B
$6.09M 3.32%
34,788
+346
+1% +$58.2K
2023 Q4
1 quarter
ASML icon
17
ASML
ASML
$680B
$4.03M 2.2%
4,151
+175
+4% +$155K
2023 Q4
1 quarter
NVO
18
Novo Nordisk
NVO
$169B
$3.98M 2.17%
30,970
-2,683
-8% -$319K
2023 Q4
1 quarter
ICLR icon
19
Icon
ICLR
$12.7B
$3.88M 2.11%
11,550
+471
+4% +$139K
2023 Q4
1 quarter
TSM icon
20
TSMC
TSM
$2.38T
$2.88M 1.57%
21,152
+856
+4% +$106K
2023 Q4
1 quarter
BNS icon
21
Scotiabank
BNS
$107B
$2.35M 1.28%
45,411
+22,341
+97% +$1.07M
2023 Q4
1 quarter
UL icon
22
Unilever
UL
$133B
$1.6M 0.87%
+28,328
New +$1.57M
2024 Q1
0 quarters
SHEL icon
23
Shell
SHEL
$285B
$1.53M 0.84%
22,859
+938
+4% +$60.1K
2023 Q4
1 quarter
NVS icon
24
Novartis
NVS
$272B
$1.39M 0.76%
14,379
+588
+4% +$60.3K
2023 Q4
1 quarter
ABEV icon
25
Ambev
ABEV
$49.2B
$1.19M 0.65%
477,913
+18,881
+4% +$49.2K
2023 Q4
1 quarter

Similar funds

Eldred Rock Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Eldred Rock Partners held 27 positions worth $183M, up 17% from $157M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eldred Rock Partners's Q1 2024 filing shows 2 new, 22 increased, 1 reduced and 1 closed positions. Its largest new stake was International Bancshares: 138,321 shares worth $7.77M. The largest sale was C.H. Robinson, an estimated $6.21M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.

  • Eldred Rock Partners's largest Q1 2024 buy was International Bancshares: 138,321 shares worth $7.77M.
  • Eldred Rock Partners added most to Scotiabank in Q1 2024, an estimated $1.07M increase.
  • Eldred Rock Partners's biggest Q1 2024 reduction was Novo Nordisk, cutting an estimated $319K.
  • Eldred Rock Partners fully exited C.H. Robinson in Q1 2024, selling an estimated $6.21M.
  • Eldred Rock Partners's ten largest holdings make up 62% of its $183M portfolio in Q1 2024.
  • Eldred Rock Partners opened 2 new positions and closed 1 in Q1 2024.
  • Eldred Rock Partners's portfolio value rose 17% quarter-over-quarter to $183M.

Based on Eldred Rock Partners's 13F filing for Q1 2024, filed 11 Apr 2024.